Achieving PSA < 0.2 ng/ml before Radiation Therapy Is a Strong Predictor of Treatment Success in Patients with High-Risk Locally Advanced Prostate Cancer.
Akira KazamaToshihiro SaitoKeisuke TakedaKazuhiro KobayashiToshiki TanikawaAyae KanemotoFumio AyukawaYasuo MatsumotoTadashi SugitaNoboru HaraYoshihiko TomitaPublished in: Prostate cancer (2019)
In patient with high-risk prostate cancer, RT plus ADT achieved good oncologic outcomes. PSA < 0.2 ng/ml before radiation therapy is a strong independent predictor for long overall survival.